Bristol Myers Squibb revealed a new brand, including a new logo and website, after its acquisition of Celgene, Medical, Marketing and Media reported. The FTC approved Bristol-Myers’ $74 billion ...

Bristol Myers Squibb unveiled its new corporate identity this week. Gone is the old blue logo, geometric glyph and hyphenated name. The new BMS logo, meant to symbolize the company BMS has become ...

The rebranding, with a new logo and website, is meant to unify the BMS and Celgene brands and reintroduce the company to the market post-acquisition. “We realized that the deal with Celgene was so ...

We believe that Bristol Myers Squibb stock (NYSE: BMY) is currently a better pick than its industry peer, Eli Lilly stock (NYSE: LLY), given its better growth prospects. Eli Lilly is trading at 10 ...

NEW YORK (Reuters) - Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for three drugs, 1-1/2 months ...

Bristol Myers Squibb stock (NYSE: BMY) reported its Q2 results last week, ... UKRAINE - 2021/04/19: In this photo illustration, Bristol-Myers Squibb Company logo seen displayed ...

Bristol Myers Forecasts Steeper Drop in 2025 Revenue, ... FILE PHOTO: Test tubes are seen in front of a displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021.